These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2428691)

  • 1. Reversibility of the acute toxic effect of cyclosporin A on pancreatic B cells of Wistar rats.
    Hahn HJ; Dunger A; Laube F; Besch W; Radloff E; Kauert C; Kotzke G
    Diabetologia; 1986 Aug; 29(8):489-94. PubMed ID: 2428691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of pancreatic B-cells in Wistar rats treated with non-diabetogenic doses of cyclosporin A.
    Hahn HJ; Laube R; Lucke S; Besch W
    Pharmacol Toxicol; 1992 Mar; 70(3):188-91. PubMed ID: 1579544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the cyclosporin A toxicity on rat pancreatic B-cells modulated by the MHC?
    Hahn HJ; Laube R; Klöting I
    Exp Clin Endocrinol; 1989 May; 93(2-3):203-7. PubMed ID: 2673814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats.
    Helmchen U; Schmidt WE; Siegel EG; Creutzfeldt W
    Diabetologia; 1984 Sep; 27(3):416-8. PubMed ID: 6389245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology of the endocrine pancreas in cyclosporine-treated glucose-intolerant Wistar rats.
    Lucke S; Radloff E; Laube R; Hahn HJ
    Anat Anz; 1991; 172(5):351-8. PubMed ID: 1897728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of a diabetes-like syndrome by cyclosporine in Wistar rats and its reversibility after drug withdrawal.
    Hahn HJ; Kauert C; Kotzke G
    Exp Clin Endocrinol; 1987 Aug; 90(1):46-50. PubMed ID: 3311780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The action of cyclosporin A on the endocrine pancreas in vitro--functional and morphological studies.
    Laube F; Blech W; Schröder D; Besch W; Hildebrandt W; Hahn HJ
    Exp Clin Endocrinol; 1986 Jun; 87(1):69-78. PubMed ID: 3527725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of toxic effects of cyclosporin on pancreatic B-cells of rats by Rioprostil, a new prostaglandin analogue.
    Müller MK; Degenhardt H; Klöppel G; Goebell H; Bergmann K; Löhr M
    Gut; 1988 Nov; 29(11):1524-30. PubMed ID: 3145244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of prednisolone on cyclosporin-induced damage of pancreatic B cells in Wistar rats.
    Hamaguchi K; Nakamura M; Ono J; Takaki R
    Diabetes Res Clin Pract; 1989 Apr; 6(3):177-84. PubMed ID: 2656167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats.
    Hahn HJ; Laube F; Lucke S; Klöting I; Kohnert KD; Warzock R
    Transplantation; 1986 Jan; 41(1):44-7. PubMed ID: 3510493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin analogue protects pancreatic B-cells against cyclosporin A toxicity.
    Löhr M; Müller MK; Goebell H; Klöppel G
    Experientia; 1989 Apr; 45(4):352-5. PubMed ID: 2495978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural and functional studies of pancreatic B cells in Wistar rats treated with immunotherapeutic doses of cyclosporin.
    Hamaguchi K; Nakamura M; Ono J; Takaki R
    Diabetes Res Clin Pract; 1988 Jul; 5(2):135-43. PubMed ID: 3046879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
    Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
    Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of prostaglandin metabolism by K-MAP and prevention of toxic effect of cyclosporin on pancreatic islet cells.
    Teraoka S; Kawai T; Babazono T; Fuchinoue S; Honda H; Nakajima I; Fujikawa H; Hayashi T; Nakagawa Y; Fujita S
    Diabetes; 1989 Jan; 38 Suppl 1():120-5. PubMed ID: 2642833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cyclosporin A on rat pancreatic B-cell: interaction with the calcium-antagonist diltiazem.
    Stöckmann F; Fehmann HC; Haverich R; Göke B; Creutzfeldt W
    Exp Clin Endocrinol; 1989 May; 93(2-3):213-8. PubMed ID: 2673816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells.
    Robertson RP
    Diabetes; 1986 Sep; 35(9):1016-9. PubMed ID: 3527823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total parenteral nutrition modulates hormone release by stimulating expression and activity of inducible nitric oxide synthase in rat pancreatic islets.
    Salehi A; Ekelund M; Henningsson R; Lundquist I
    Endocrine; 2001 Nov; 16(2):97-104. PubMed ID: 11887940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat.
    Ostenson CG; Khan A; Abdel-Halim SM; Guenifi A; Suzuki K; Goto Y; Efendic S
    Diabetologia; 1993 Jan; 36(1):3-8. PubMed ID: 8436249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclosporin A on the endocrine pancreas of the rat. Morphological and immunohistochemical studies.
    Jablenska R; Ogneva V; Petkov P
    Acta Diabetol Lat; 1989; 26(1):43-9. PubMed ID: 2568725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prolonged administration of cyclosporin A on (pro)insulin biosynthesis and insulin release by rat islets of Langerhans.
    Chandrasekar B; Mukherjee SK
    Biochem Pharmacol; 1988 Oct; 37(19):3609-11. PubMed ID: 3052458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.